Inactivation of human glucose 6-phosphate dehydrogenase (G6PDH) by peroxyl radicals is strongly modulated by its substrate and cofactor
Abstract
Glucose 6-phosphate dehydrogenase (G6PDH) is the rate-limiting enzyme of the pentose phosphate pathway (PPP). This enzyme catalyzes the oxidation of glucose 6-phosphate (G6P) into 6-phosphogluconolactone with concomitant reduction of NADP+ to NADPH. Despite the link between the PPP and oxidative stress, the oxidation and consequences on the activity of the human G6PDH (hG6PDH) has not been investigated. In the present work we report the oxidative inactivation of hG6PDH mediated by peroxyl radicals (ROO center dot) generated by AAPH (2,2 '- azobis(2-methylpropionamidine) dihydrochloride) thermolysis. hG6PDH (46.4 mu M, monomers) was incubated at 37 degrees C with 10 or 100 mM AAPH. At defined times, enzyme activity was determined (NADPH release followed at 340 nm), mapping of modifications studied by LC-MS, structural changes analyzed by circular dichroism, and results rationalized by in silico analysis of the three-dimensional structure of the enzyme. Analogous experiments were developed in the presence of NADP+ or G6P at excess or 1:1 (hG6PDH:NADP+ or G6P) molar ratios. High susceptibility to inactivation by ROO center dot was observed, 3.6 mol of ROO center dot inactivated 1 mol of hG6PDH. This behavior is rationalized, at least in part, by oxidation at Trp349 which is located close to the structural site of NADP+. The presence of G6P significantly increased the ROO center dot-mediated inactivation of hG6PDH, while an opposite effect was observed in the presence of NADP+ where, despite oxidation at different sites, the enzyme activity was practically unaltered by ROO center dot. These results demonstrate that hG6PDH is highly susceptible to inactivation mediated by ROO center dot with these processes strongly modulated by G6P and NADP+.
Más información
Título según WOS: | ID WOS:001458056400001 Not found in local WOS DB |
Título de la Revista: | FREE RADICAL BIOLOGY AND MEDICINE |
Volumen: | 233 |
Editorial: | Elsevier Science Inc. |
Fecha de publicación: | 2025 |
Página de inicio: | 55 |
Página final: | 69 |
DOI: |
10.1016/j.freeradbiomed.2025.03.030 |
Notas: | ISI |